Centers for Medicare & Medicaid Services has proposed a near zero increase in Medicare Advantage payments, affecting growth ...
Earlier this week, the Centers for Medicare & Medicaid Services proposed a roughly flat 0.09% payment increase for 2027 ...
Shares of large Medicare plan providers Humana, CVS Health and UnitedHealth Group plunged in extended trading.
Investing.com -- Morgan Stanley downgraded Humana to Underweight from Equal-weight, warning that policy risks and the company ...
A federal proposal targeting Medicare Advantage payments sent Louisville-based Humana’s stock down about 20% Tuesday and ...
Humana stock plunged 21% after a shockingly low Medicare Advantage rate proposal threatens margins and clouds the insurer’s outlook.
That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.
Humana is modifying its Medicare Advantage products for 2025 amid industrywide struggles with higher costs under the program, the company announced along with its second-quarter results Wednesday.
Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...
Humana is one of the many Medicare-approved private insurance companies that offer Medicare Advantage (Part C) plans. These plans are an alternative to Original Medicare (Part A and Part B) plans.
Although hospital-owned plans are only a sliver of the Medicare Advantage market, their enrollment continues to grow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results